Chengdu Climb Pharmaceutical Technology Co., Ltd.
|
please call me , to know more |
Send Inquiry
|
Sichuan Omnis Pharmaceutical Co., Ltd.
|
Currently Apixaban is under development, and estimated to market in the end of 2019.
|
Send Inquiry
|
J&K Scientific
|
【产品名称】:依托考昔
【Product Name】:Etoricoxib, 98%, a non steroidal anti-inflammatory agent, acting as a selective and orally active COX-2 inhibitor, with IC50s of 1.1 μM and 116 μM for COX-2 and COX-1 in human whole blood
【产品规格】:一种非甾体抗炎剂, 为可口服的, 选择性的COX-2抑制剂, 对人全血COX-2和COX-1的IC50值分别为1.1 μM和116 μM
【CAS】:202409-33-4
【MP】:134-135℃
【Density】:1.298
【Storage】:Freezer -20℃ |
Send Inquiry
|